Literature DB >> 28710239

Anaphylaxis secondary to Parietaria judaica (wall pellitory).

Chiara Vella1, Patrick Sammut1.   

Abstract

Aeroallergens are an unusual cause of anaphylaxis with sparse reports in the literature. We describe a case of suspected anaphylaxis to Parietaria judaica pollen and the difficulties encountered in confirming this diagnosis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  allergy; asthma; paediatrics

Mesh：

Substances：

Year:  2017        PMID： 28710239      PMCID： PMC5535051          DOI： 10.1136/bcr-2017-220309

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  10 in total

1.  Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance.

Authors:  M Ferrer; E Burches; A Peláez; A Muñoz; D Hernández; A Basomba; E Enrique; R Alonso; A Cisteró-Bahima; S Martín; P Rico; B Gandarias
Journal:  J Investig Allergol Clin Immunol       Date:  2005       Impact factor: 4.333

2.  Grass pollen triggered anaphylaxis in an adolescent boy.

Authors:  H Haluk Akar; M Akif Goktas; F Tahan
Journal:  Eur Ann Allergy Clin Immunol       Date:  2015-01

3.  A rare cause of aeroallergen-induced anaphylaxis: horse allergy.

Authors:  Özlem Cavkaytar; Özge Soyer; Bülent Enis Şekerel
Journal:  Turk J Pediatr       Date:  2014 Jul-Aug       Impact factor: 0.552

4.  Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis.

Authors:  Joachim Kuehr; Jens Brauburger; Stefan Zielen; Uwe Schauer; Wolfgang Kamin; Andrea Von Berg; Wolfgang Leupold; Karl-Christian Bergmann; Claudia Rolinck-Werninghaus; Michael Gräve; Thomas Hultsch; Ulrich Wahn
Journal:  J Allergy Clin Immunol       Date:  2002-02       Impact factor: 10.793

5.  Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study.

Authors:  Mariona Pinart; Marta Benet; Isabella Annesi-Maesano; Andrea von Berg; Dietrich Berdel; Karin C L Carlsen; Kai-Håkon Carlsen; Carsten Bindslev-Jensen; Esben Eller; Maria P Fantini; Jacopo Lenzi; Ulrike Gehring; Joachim Heinrich; Cynthia Hohmann; Jocelyne Just; Thomas Keil; Marjan Kerkhof; Manolis Kogevinas; Sibylle Koletzko; Gerard H Koppelman; Inger Kull; Susanne Lau; Erik Melén; Isabelle Momas; Daniela Porta; Dirkje S Postma; Fanny Rancière; Henriette A Smit; Renato T Stein; Christina G Tischer; Maties Torrent; Magnus Wickman; Alet H Wijga; Jean Bousquet; Jordi Sunyer; Xavier Basagaña; Stefano Guerra; Judith Garcia-Aymerich; Josep M Antó
Journal:  Lancet Respir Med       Date:  2014-01-14       Impact factor: 30.700

6.  Anaphylaxis: underdiagnosed, underreported, and undertreated.

Authors:  David A Sclar; Phillip L Lieberman
Journal:  Am J Med       Date:  2013-09-30       Impact factor: 4.965

Review 7.  Omalizumab for treatment of allergic rhinitis.

Authors:  Priyanka Vashisht; Thomas Casale
Journal:  Expert Opin Biol Ther       Date:  2013-04-29       Impact factor: 4.388

Review 8.  Anaphylaxis in children: current understanding and key issues in diagnosis and treatment.

Authors:  Chitra Dinakar
Journal:  Curr Allergy Asthma Rep       Date:  2012-12       Impact factor: 4.806

9.  Successful desensitization in a boy with severe cow's milk allergy by a combination therapy using omalizumab and rush oral immunotherapy.

Authors:  Masaya Takahashi; Shoichiro Taniuchi; Kazuhiko Soejima; Yasuko Hatano; Sohsaku Yamanouchi; Kazunari Kaneko
Journal:  Allergy Asthma Clin Immunol       Date:  2015-05-28       Impact factor: 3.406

Review 10.  Pollen Allergens for Molecular Diagnosis.

Authors:  Isabel Pablos; Sabrina Wildner; Claudia Asam; Michael Wallner; Gabriele Gadermaier
Journal:  Curr Allergy Asthma Rep       Date:  2016-04       Impact factor: 4.806
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.